Related Experiment Videos
Neuronal death in brain infarcts in man
S Love1, R Barber, G K Wilcock
1Departments of Neuropathology, Care of the Elderly, Frenchay Hospital, Bristol, UK. seth.love@bris.ac.uk
Neuropathology and Applied Neurobiology
|March 29, 2000
Summary
Neuronal death in human brain infarcts shows early programmed cell death markers like caspase-3 (CASP3) upregulation but lacks typical apoptosis morphology. DNA cleavage is delayed, and TUNEL staining may be artifactual.
Area of Science:
- Neuroscience
- Pathology
- Cell Biology
Background:
- The precise mechanisms of neuronal death in brain ischemia are not fully understood.
- Investigating cell death pathways is crucial for developing effective treatments for stroke.
Purpose of the Study:
- To elucidate the mechanisms of neuronal death in human brain infarcts.
- To differentiate between apoptosis and other forms of cell death in ischemic brain injury.
Main Methods:
- Utilized morphological analysis, terminal transferase-mediated dUTP-digoxigenin nick end-labeling (TUNEL), and immunohistochemistry.
- Examined markers of apoptosis and DNA damage, including caspase-3 (CASP3), poly(ADP-ribose) polymerase (PARP), and DNA-dependent protein kinase catalytic subunit (DNA-PKCS).
- Analyzed brain infarcts from 35 human subjects across a range of ages and infarct durations.
Main Results:
- Neuronal death exhibited morphological features distinct from classical apoptosis.
- Early upregulation of CASP3 was observed in neurons within infarcts, alongside a rapid decline in DNA-PKCS and PARP.
- TUNEL labeling was present but potentially confounded by endogenous nucleases, and apoptotic bodies were mainly associated with non-neuronal cells.
Conclusions:
- Human brain infarcts display early biochemical signs of programmed cell death, including CASP3 activation.
- However, the characteristic morphology and timing of DNA fragmentation do not align with typical apoptosis.
- Findings suggest a complex cell death process in ischemic stroke, with potential contributions from endogenous nucleases and inflammatory responses.